Skip to main content
. 2011 Oct 18;152(12):4974–4983. doi: 10.1210/en.2011-1182

Fig. 3.

Fig. 3.

Fetal ovarian miRNA expression affected by prenatal T (T) and T plus AR antagonist (TF) treatment as determined by quantitative RT-PCR of miRNA from whole ovarian tissue from fetal d 90. Treatment effects on expression of miRNA were determined by one-way ANOVA followed by Dunnett's post hoc tests. Asterisks indicate significant differences from control (P < 0.05). Note for miR-29a (bottom panel) the T group showed a tendency to be higher than controls (P = 0.0613).

HHS Vulnerability Disclosure